Why the study?
Cardiovascular disease contributes to morbidity and mortality after liver transplantation, but the progression of cardiac function and remodeling in recipients remains poorly understood.
How does cardiac function and structure progress in adult liver transplant recipients, and can pre-transplant echocardiography predict prognosis?
How does cardiac function and structure progress in adult liver transplant recipients, and can pre-transplant echocardiography predict prognosis?
Answers are grounded in this paper and cite their sources.
Echocardiographic assessment reveals that liver transplantation leads to worsened systolic but improved diastolic function, with pre-transplant parameters predicting long-term mortality and heart failure.
Background & Aims Cardiovascular disease contributes to a high rate of morbidity and mortality after liver transplantation (LT). However, the progression of cardiac function and cardiac remodeling in LT recipients remains poorly understood. This study sought to evaluate the progression of cardiac function and structure in LT recipients and identify independent predictors of prognosis using echocardiography. Methods From 2009 to 2019, 178 adult LT recipients at a tertiary academic transplant center were retrospectively studied. Transthoracic echocardiograms 1‐year pre‐ and post‐LT were assessed. Primary outcomes were progression of systolic and diastolic function. Secondary outcomes included left ventricular remodeling, all‐cause mortality, and heart failure readmission post‐LT. Subgroup analyzes were performed for etiology of native liver disease. A multivariable model was constructed to examine independent predictors of outcomes. Results Systolic function significantly worsened, with reduction in stroke volume (45–37 ml/m 2 , p < .001), left ventricular ejection fraction (LVEF) (65%–62%, p < .001) and cardiac index (3.00–2.60 L/min/m 2 , p < .001). Conversely, there were significant improvements in diastolic indices, including tricuspid regurgitation V max (228–215 cm/s, p = .017), left atrial volume index (LAVI) (32–26 ml/m 2 , p < .001) and right ventricular systolic pressure (RVSP) (31–28 mmHg, p = .001). Additionally, patients had increased relative wall thickness (RWT) ( p < .001) and decreased left ventricular end‐diastolic dimension/body surface area ( p < .001) post‐LT. The independent predictors for all‐cause mortality and heart failure were increased pre‐LT mitral annular early diastolic velocity (HR 1.11, CI 1.02–1.22, p = .018), LAVI (HR 1.06, CI 1.02–1.11, p = .007) and decreased LVEF (HR .89, CI .82–.97, p = .006). The effect of non‐alcoholic steatohepatitis on cardiovascular outcomes post‐LT was largely comparable to that of Hepatitis B. Conclusion This study showed reduced systolic and improved diastolic function in LT recipients and highlighted the utility of pre‐LT echocardiogram in the prognostication and risk stratification of LT candidates.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: